These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28712002)

  • 61. Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations.
    Schara U; Christen HJ; Durmus H; Hietala M; Krabetz K; Rodolico C; Schreiber G; Topaloglu H; Talim B; Voss W; Pihko H; Abicht A; Müller JS; Lochmüller H
    Eur J Paediatr Neurol; 2010 Jul; 14(4):326-33. PubMed ID: 19900826
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Limb-girdle congenital myasthenic syndrome in a Chinese family with novel mutations in MUSK gene and literature review.
    Luan X; Tian W; Cao L
    Clin Neurol Neurosurg; 2016 Nov; 150():41-45. PubMed ID: 27588369
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering.
    Maselli RA; Dunne V; Pascual-Pascual SI; Bowe C; Agius M; Frank R; Wollmann RL
    Muscle Nerve; 2003 Sep; 28(3):293-301. PubMed ID: 12929188
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Choline acetyltransferase mutations in myasthenic syndrome due to deficient acetylcholine resynthesis.
    Maselli RA; Chen D; Mo D; Bowe C; Fenton G; Wollmann RL
    Muscle Nerve; 2003 Feb; 27(2):180-7. PubMed ID: 12548525
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A new mouse model for the slow-channel congenital myasthenic syndrome induced by the AChR εL221F mutation.
    Chevessier F; Peter C; Mersdorf U; Girard E; Krejci E; McArdle JJ; Witzemann V
    Neurobiol Dis; 2012 Mar; 45(3):851-61. PubMed ID: 22178625
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies.
    Robb SA; Sewry CA; Dowling JJ; Feng L; Cullup T; Lillis S; Abbs S; Lees MM; Laporte J; Manzur AY; Knight RK; Mills KR; Pike MG; Kress W; Beeson D; Jungbluth H; Pitt MC; Muntoni F
    Neuromuscul Disord; 2011 Jun; 21(6):379-86. PubMed ID: 21440438
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Familial neuromuscular disease with tubular aggregates.
    Pierobon-Bormioli S; Armani M; Ringel SP; Angelini C; Vergani L; Betto R; Salviati G
    Muscle Nerve; 1985 May; 8(4):291-8. PubMed ID: 16758595
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A CHRNE frameshift mutation causes congenital myasthenic syndrome in young Jack Russell Terriers.
    Rinz CJ; Lennon VA; James F; Thoreson JB; Tsai KL; Starr-Moss AN; Humphries HD; Guo LT; Palmer AC; Clark LA; Shelton GD
    Neuromuscul Disord; 2015 Dec; 25(12):921-7. PubMed ID: 26429099
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tubular aggregates in autoimmune Lambert-Eaton myasthenic syndrome.
    Cordts I; Funk F; Schulz JB; Weis J; Claeys KG
    Neuromuscul Disord; 2016 Dec; 26(12):880-884. PubMed ID: 27816328
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Congenital myasthenic syndromes.
    Harper CM
    Semin Neurol; 2004 Mar; 24(1):111-23. PubMed ID: 15229798
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Congenital myasthenic syndromes.
    Finsterer J
    Orphanet J Rare Dis; 2019 Feb; 14(1):57. PubMed ID: 30808424
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission.
    Müller JS; Mihaylova V; Abicht A; Lochmüller H
    Expert Rev Mol Med; 2007 Aug; 9(22):1-20. PubMed ID: 17686188
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical and Genetic Features of Congenital Myasthenic Syndromes due to CHAT Mutations: Case Report and Literature Review.
    Arican P; Gencpinar P; Cavusoglu D; Olgac Dundar N
    Neuropediatrics; 2018 Aug; 49(4):283-288. PubMed ID: 29783273
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tubular aggregate myopathy: a case report.
    Kim NR; Suh YL
    J Korean Med Sci; 2003 Feb; 18(1):135-40. PubMed ID: 12589105
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Myasthenia gravis and congenital myasthenic syndromes in dogs and cats: A history and mini-review.
    Shelton GD
    Neuromuscul Disord; 2016 Jun; 26(6):331-4. PubMed ID: 27080328
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
    Lashley D; Palace J; Jayawant S; Robb S; Beeson D
    Neurology; 2010 May; 74(19):1517-23. PubMed ID: 20458068
    [TBL] [Abstract][Full Text] [Related]  

  • 77. DPAGT1 myasthenia and myopathy: genetic, phenotypic, and expression studies.
    Selcen D; Shen XM; Brengman J; Li Y; Stans AA; Wieben E; Engel AG
    Neurology; 2014 May; 82(20):1822-30. PubMed ID: 24759841
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Molecular bases and therapeutic strategies in defective neuromuscular transmissions: lessons learned from a prototypical synapse].
    Ohno K; Ito M; Masuda A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Aug; 29(4):145-51. PubMed ID: 19764481
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Studies on therapeutic strategies for congenital myasthenic syndromes.].
    Ohno K
    Clin Calcium; 2017; 27(3):421-428. PubMed ID: 28232657
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The congenital myasthenic syndromes.
    Palace J; Beeson D
    J Neuroimmunol; 2008 Sep; 201-202():2-5. PubMed ID: 18708269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.